|
1
|
Hu YL, Fu YH, Tabata Y and Gao JQ:
Mesenchymal stem cells: A promising targeted-delivery vehicle in
cancer gene therapy. J Control Release. 147:154–162. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Drissi H, Gibson JD, Guzzo RM and Xu RH:
Derivation and chondrogenic commitment of human embryonic stem
cell-derived mesenchymal progenitors. Methods Mol Biol. 1340:65–78.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown PT, Squire MW and Li WJ:
Characterization and evaluation of mesenchymal stem cells derived
from human embryonic stem cells and bone marrow. Cell Tissue Res.
358:149–164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang H, Bai M, Deng T, Liu R, Wang X, Qu
Y, Duan J, Zhang L, Ning T, Ge S, et al: Cell-derived microvesicles
mediate the delivery of miR-29a/c to suppress angiogenesis in
gastric carcinoma. Cancer Lett. 375:331–339. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu S, Ju GQ, Du T, Zhu YJ and Liu GH:
Microvesicles derived from human umbilical cord Wharton's jelly
mesenchymal stem cells attenuate bladder tumor cell growth in vitro
and in vivo. PLoS One. 8:e613662013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fonsato V, Collino F, Herrera MB,
Cavallari C, Deregibus MC, Cisterna B, Bruno S, Romagnoli R,
Salizzoni M, Tetta C, et al: Human liver stem cell-derived
microvesicles inhibit hepatoma growth in SCID mice by delivering
antitumor microRNAs. Stem Cells. 30:1985–1998. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Fonseka M, Ramasamy R, Tan BC and Seow HF:
Human umbilical cord blood-derived mesenchymal stem cells
(hUCB-MSC) inhibit the proliferation of K562 (human
erythromyeloblastoid leukaemic cell line). Cell Biol Int.
36:793–801. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hu JB, Wang XH, Ma QH, Zhang W, Wang YY
and Wen XM: Preliminary investigation on the differentiation of
human embryonic stem cells into mesenchymal stem cells. Chin J Clin
Lab Sci. 31:276–278. 2013.
|
|
9
|
Gadkari R, Zhao L, Teklemariam T and
Hantash BM: Human embryonic stem cell derived-mesenchymal stem
cells: An alternative mesenchymal stem cell source for regenerative
medicine therapy. Regen Med. 9:453–465. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bruno S, Collino F, Deregibus MC, Grange
C, Tetta C and Camussi G: Microvesicles derived from human bone
marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev.
22:758–771. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song N, Gao L, Qiu H, Huang C, Cheng H,
Zhou H, Lv S, Chen L and Wang J: Mouse bone marrow-derived
mesenchymal stem cells inhibit leukemia/lymphoma cell proliferation
in vitro and in a mouse model of allogeneic bone marrow
transplant. Int J Mol Med. 36:139–149. 2015.PubMed/NCBI
|
|
12
|
Ramasamy R, Lam EW, Soeiro I, Tisato V,
Bonnet D and Dazzi F: Mesenchymal stem cells inhibit proliferation
and apoptosis of tumor cells: Impact on in vivo tumor growth.
Leukemia. 21:304–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Goldstein RH, Reagan MR, Anderson K,
Kaplan DL and Rosenblatt M: Human bone marrow-derived MSCs can home
to orthotopic breast cancer tumors and promote bone metastasis.
Cancer Res. 70:10044–10050. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Psaila B, Kaplan RN, Port ER and Lyden D:
Priming the ‘soil’ for breast cancer metastasis: The pre-metastatic
niche. Breast Dis. 26:65–74. 2006.2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo F, Liu T, Wang J, Li J, Ma P, Ding H,
Feng G, Lin D, Xu Y and Yang K: Bone marrow mesenchymal stem cells
participate in prostate carcinogenesis and promote growth of
prostate cancer by cell fusion in vivo. Oncotarget. 7:30924–30934.
2016.PubMed/NCBI
|
|
16
|
Burns JS, Abdallah BM, Guldberg P, Rygaard
J, Schrøder HD and Kassem M: Tumorigenic heterogeneity in cancer
stem cells evolved from long-term cultures of
telomerase-immortalized human mesenchymal stem cells. Cancer Res.
65:3126–3135. 2005.PubMed/NCBI
|
|
17
|
Raposo G and Stoorvogel W: Extracellular
vesicles: Exosomes, microvesicles, and friends. J Cell Biol.
200:373–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gambim MH, do Carmo AO, Marti L,
Veríssimo-Filho S, Lopes LR and Janiszewski M: Platelet-derived
exosomes induce endothelial cell apoptosis through peroxynitrite
generation: Experimental evidence for a novel mechanism of septic
vascular dysfunction. Crit Care. 11:R1072007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang L, Wu X, Wang D, Luo C and Chen L:
Renal carcinoma cell-derived exosomes induce human immortalized
line of Jurkat T lymphocyte apoptosis in vitro. Urol Int.
91:363–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Fulda S and Kögel D: Cell death by
autophagy: Emerging molecular mechanisms and implications for
cancer therapy. Oncogene. 34:5105–5113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu L, Alva A, Su H, Dutt P, Freundt E,
Welsh S, Baehrecke EH and Lenardo MJ: Regulation of an ATG7-beclin
1 program of autophagic cell death by caspase-8. Science.
304:1500–1502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Borthakur G, Duvvuri S, Ruvolo V, Tripathi
DN, Piya S, Burks J, Jacamo R, Kojima K, Ruvolo P, Fueyo-Margareto
J, et al: MDM2 inhibitor, nutlin 3a, induces p53 dependent
autophagy in acute leukemia by AMP kinase activation. PLoS One.
10:e01392542015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Paglin S, Hollister T, Delohery T, Hackett
N, McMahill M, Sphicas E, Domingo D and Yahalom J: A novel response
of cancer cells to radiation involves autophagy and formation of
acidic vesicles. Cancer Res. 61:439–444. 2001.PubMed/NCBI
|
|
25
|
Fu LL, Cheng Y and Liu B: Beclin-1:
Autophagic regulator and therapeutic target in cancer. Int J
Biochem Cell Biol. 45:921–924. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liang XH, Jackson S, Seaman M, Brown K,
Kempkes B, Hibshoosh H and Levine B: Induction of autophagy and
inhibition of tumorigenesis by beclin 1. Nature. 402:672–676. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
White E: The role for autophagy in cancer.
J Clin Invest. 125:42–46. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yang C, Kaushal V, Shah SV and Kaushal GP:
Autophagy is associated with apoptosis in cisplatin injury to renal
tubular epithelial cells. Am J Physiol Renal Physiol.
294:F777–F787. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kroemer G and Levine B: Autophagic cell
death: The story of a misnomer. Nat Rev Mol Cell Biol. 9:1004–1010.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gump JM and Thorburn A: Autophagy and
apoptosis: What is the connection? Trends Cell Biol. 21:387–392.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Campisi J: Senescent cells, tumor
suppression, and organismal aging: Good citizens, bad neighbors.
Cell. 120:513–522. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zaharie F, Muresan MS, Petrushev B, Berce
C, Gafencu GA, Selicean S, Jurj A, Cojocneanu-Petric R, Lisencu CI,
Pop LA, et al: Exosome-carried microRNA-375 inhibits cell
progression and dissemination via Bcl-2 blocking in colon cancer. J
Gastrointestin Liver Dis. 24:435–443. 2015.PubMed/NCBI
|
|
34
|
Ristorcelli E, Beraud E, Mathieu S,
Lombardo D and Verine A: Essential role of Notch signaling in
apoptosis of human pancreatic tumoral cells mediated by exosomal
nanoparticles. Int J Cancer. 125:1016–1026. 2009. View Article : Google Scholar : PubMed/NCBI
|
